Dedicated to the advancement of cardiovascular intervention
BioCardia®, Inc. is a clinical-stage biotech-regenerative medicine company that develops innovative therapeutics for the treatment of cardiovascular disease.
Arterial Vascular Engineering (acquired by Medtronic, Inc.)
Acquired by Medtronic, Inc. in 1998, Arterial Vascular Engineering (AVE) developed coronary stents and balloon angioplasty catheters used to treat coronary artery disease.
Quanam Medical Corporation (acquired by Boston Scientific)
Founded in 1994, Quanam Medical Corporation developed polymer coated stents used for drug delivery in coronary angioplasty. It was acquired by Boston Scientific in 2001.
Founded in 1999 and now a public company, CareDx seeks to improve the quality of life of organ transplant patients through the use of non-invasive, diagonistic survelliance solutions.
Lumen Therapeutics is a privately held, development stage biopharmaceutical company focused on proprietary drugs based on oligo-L-arginine.
Since the website was set up, I have become a member of the scientific advisory board of Avenda Health, a startup company in Los Angeles, designed to drastically simplify the treatment for the majority of men’s prostate cancers. The Avenda Health platform delivers targeted treatment through focal laser ablation, minimizing the impact to healthy tissue. When compared to competing technologies, this ‘male lumpectomy’ is relatively inexpensive (no operating room), simple (local anaesthesia), and quick (under an hour).